The Point Podcast
The Texas Heart Institute produces The Point to discuss newly published clinical research and emerging developments and innovations in patient care. Designed to infuse your day with the latest medical knowledge and a dash of banter, faculty, and fellows dive into newly published research and its significance to patient care today and in the future.
Where to listen to this podcast: https://www.texasheart.org/office-of-education/podcasts/
-
Serendipitous Beginnings for SGLT Inhibitors: A Cardiology Primer
The Texas Heart Institute’s Drs. Salim Virani and Matthew Segar look back at the history of Sglt2 inhibitors, which have roots in a fascinating FDA initiative focused on cardiovascular outcomes in diabetes medications. They explore the serendipitous beginnings of these groundbreaking medicines an...